You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

LIDOCATON Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Lidocaton, and when can generic versions of Lidocaton launch?

Lidocaton is a drug marketed by Pharmaton and is included in three NDAs.

The generic ingredient in LIDOCATON is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Lidocaton

A generic version of LIDOCATON was approved as lidocaine hydrochloride by WOCKHARDT BIO AG on November 18th, 1982.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for LIDOCATON?
  • What are the global sales for LIDOCATON?
  • What is Average Wholesale Price for LIDOCATON?
Summary for LIDOCATON
US Patents:0
Applicants:1
NDAs:3
Raw Ingredient (Bulk) Api Vendors: 197
Patent Applications: 4,526
DailyMed Link:LIDOCATON at DailyMed
Drug patent expirations by year for LIDOCATON

US Patents and Regulatory Information for LIDOCATON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmaton LIDOCATON epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 084729-001 Aug 17, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharmaton LIDOCATON epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 084728-001 Aug 17, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharmaton LIDOCATON lidocaine hydrochloride INJECTABLE;INJECTION 084727-001 Aug 17, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.